FDA Clearance Tracker · P040021-S011
SJM BIOCOR, BIOCOR SUPRA, EPIC AND EPIC SUPRA HEART VALVES
Last checked: Nov 20, 2026Latest source record: Oct 2, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Oct 2, 2009
Approved
Time to decision
46 days
Received Aug 17, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040021-S011
- Device name
- SJM BIOCOR, BIOCOR SUPRA, EPIC AND EPIC SUPRA HEART VALVES
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Aug 17, 2009
- Decided
- Oct 2, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040021
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ST. JUDE MEDICAL, WOODRIDGE FACILITY, ST. PAUL, MINNESOTA FOR BIOBURDEN REDUCTION AND CHEMICAL FIXATION OF THE BIOCOR AND EPIC FAMILY OF HEART VALVES.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.